Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxinA injection in patients with refractory detrusor overactivity.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To investigate the efficacy and safety of intravesical onabotulinumtoxinA injection
in patients with diabetes mellitus (DM) and refractory detrusor overactivity (DO).
[1
]
Department of Urology, En Chu Kong Hospital, College of Medicine, National Taiwan
University, Taipei, Taiwan; Department of Biomedical Engineering, Chung Yuan Christian
University, Chung-Li, Taiwan.